Sorin Group S.p.A. Announces First World Implant Of CROWN PRT™ Heart Valve

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MILAN--(BUSINESS WIRE)--Sorin Group (MIL:SRN), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today the first world implant of its CROWN PRT bioprosthetic aortic valve. The implant was performed in Austria at the Salzburg University Clinic by Prof. Rainald Seitelberger, M.D., and Christian Dinges, M.D.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC